The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. - Wikidata - wikimedia - TriplyDB

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

http://www.wikidata.org/entity/Q36812817

about

Parkinson's disease as a result of aging Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease.Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.Methionine in Proteins: It's Not Just for Protein Initiation Anymore.Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?An energy systems approach to Parkinson's disease.Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.

P2860

Q28084395-BE1D7849-3D78-4326-8E9B-191499183789 Q33894382-462F9F47-B521-4BA7-8176-A0040D3D98A9 Q35997646-FC629E7C-ADFD-4BD2-BB2C-B475FD769CA7 Q36499640-7E71AE77-6EC7-4007-957F-48ADD1603D0D Q36976137-78E38DC0-2AF0-47CA-98E2-041FC0BB4CB7 Q37270004-366BAD85-497F-4783-8062-F6D9D1AB6383 Q37333346-60FF3F8F-4009-49B4-A277-0C36E7CCED1B Q37363512-490055B0-94E8-4FCA-B8E0-5B2F3560AFF7 Q38570991-9D7F12F1-FA86-48DF-8852-D80CD41CF7C9 Q41758570-FDCBF13D-1F14-4014-94F4-D7514B454F8F Q48256084-AC05E90E-C3EB-4D64-9228-4785CBB96AE7 Q48946263-45702D73-CBF9-4C72-BC2B-3762B02CE952 Q51639388-88FE65D3-881A-4DC8-9DE4-56C82C3EB1A3 Q53392035-4DEF8770-1601-462F-BA93-FB5D281A8020

P2860

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

http://www.wikidata.org/entity/Q36812817

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

@ast

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

@en

type

label

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

@ast

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

@en

prefLabel

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

@ast

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

@en

P1433

Q36812817-0657FBE1-D64D-4792-9F31-947E64D684F5

P1476

Q36812817-8F2C1E35-1154-43F4-A795-325E4DF5B80A

P2093

Q36812817-17F1A579-A252-4FA7-8107-9AD84A6546D2

Q36812817-20FC9245-0873-49E8-B543-A747713D522A

Q36812817-50E96739-BB27-4331-BC1B-DD469AB73A8D

Q36812817-572387F8-4C22-4DE3-9C96-57A094ECDAA5

Q36812817-726E5108-C479-4611-9C2D-DFABB3B0069C

Q36812817-730D443B-3F36-4B9A-BFA3-9EDC1AD8E238

Q36812817-7B65EFA3-2954-4496-811D-F6286B4BD374

Q36812817-AF0F9002-9725-4A54-8717-8BCAF5083A35

Q36812817-F36BAD0D-2DA3-40CA-9F35-ED17D1C56893

Q36812817-F7802383-623E-406E-87BC-74FC1D50CA8B

P2860

Q36812817-01B1F38B-927F-4E86-AD96-B132F6B21480

Q36812817-057696AF-31AA-492A-9E9B-29DFC8ECCE0D

Q36812817-0A7BD555-D9A7-4239-85B8-713A63FE14AB

Q36812817-12A9C62D-5CB5-429E-A348-04161A2C3D3B

Q36812817-13602452-7433-4E25-A735-0472A1881604

Q36812817-1385E776-2A4E-4CAD-98CC-9749344F2749

Q36812817-2174AF07-78E1-49E7-9D6D-20153414E239

Q36812817-2464AE44-E0C0-45E9-888F-35BBA5B7C025

Q36812817-248C09A4-48E8-49D9-AFCE-9C234CCF227A

Q36812817-24DE744B-2B13-4898-93CB-DE66A95F44CA

P304

Q36812817-2011B130-B580-40D6-9D2F-BEDC31FA9A9C

P31

Q36812817-1EA40369-E389-4DCA-910F-6CC3EB5D38BC

P356

Q36812817-AAB5A003-B644-4AF8-AB33-7E1A7D00A8DF

P433

Q36812817-46BC9763-A608-48EC-97BA-FA44390EA46B

P478

Q36812817-771FAC50-6717-47E9-A83E-974375EB6089

P50

Q36812817-001B773F-6CC4-4D25-B75E-464BAAFD17C3

Q36812817-1DC4BF04-CE98-4D69-91C0-722B9A2A4ED4

Q36812817-3698391E-FB89-437B-BD25-5C52BF9E1F99

Q36812817-3845CAA3-1030-4D55-833A-A32FF760B1A0

Q36812817-9D79D520-80A5-45C7-B01C-F5FA227FCF34

Q36812817-A986D7A2-42DC-436A-A093-9B25F51DD902

Q36812817-C6B45A65-9127-4C16-8E1F-F9FC7261AC03

Q36812817-D5EEBB7F-568A-423E-8A7D-9C332A2CBE1B

Q36812817-EFD059C4-D3EF-449F-9861-AFB51AECA0C2

Q36812817-F3FA0EA9-AE79-458F-BC89-FB61ABA8375E

P577

Q36812817-9387CF0D-17DB-438D-8629-113119F3BD8B

P5875

Q36812817-B9FE6A55-6818-42FF-857B-35B408FD3D50

P698

Q36812817-CD557D49-CC07-4BA8-ADC7-502BCE202021

P921

Q36812817-D89AF215-2573-4403-B992-9F7EC5427DB8

P356

NEN.0B013E318053716A

P1433

Journal of Neuropathology & Experimental Neurology

P1476

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

@en

P2093

Charles Duyckaerts

http://www.w3.org/2001/XMLSchema#string

Davis Parker

http://www.w3.org/2001/XMLSchema#string

Donald Price

http://www.w3.org/2001/XMLSchema#string

Donato A Di Monte

http://www.w3.org/2001/XMLSchema#string

Eldad Melamed

http://www.w3.org/2001/XMLSchema#string

Peter Jenner

http://www.w3.org/2001/XMLSchema#string

Theo Hagg

http://www.w3.org/2001/XMLSchema#string

Walter Rocca

http://www.w3.org/2001/XMLSchema#string

William J Langston

http://www.w3.org/2001/XMLSchema#string

Yoav Ben-Shlomo

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

High-resolution whole-genome association study of Parkinson disease.

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration

Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

P304

329-336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/NEN.0B013E318053716A

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Dennis W. Dickson

Richard H Myers

Glenda Halliday

John Anthony Hardy

Christopher G. Goetz

Marie-Françoise Chesselet

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6347099

http://www.w3.org/2001/XMLSchema#string

P698

17483689

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease